Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-21-000589
Filing Date
2021-03-02
Accepted
2021-03-02 15:33:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da112227005_03022021.htm SC 13D/A 78718
  Complete submission text file 0000921895-21-000589.txt   80563
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Subject) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50777 | Film No.: 21703196
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR. NEW YORK NY 10036 212-520-1819
Custodian Ventures LLC. (Filed by) CIK: 0001830402 (see all company filings)

EIN.: 824343920 | State of Incorp.: WY | Fiscal Year End: 1231
Type: SC 13D/A